Squarepoint
LEGN icon

Squarepoint’s Legend Biotech LEGN Stock Holding History

Squarepoint’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.2M Buy
769,252
+289,772
+60% +$7.82M 0.02% 654
2026
Q1 		$8.67M Buy
479,480
+69,506
+17% +$1.33M 0.01% 1152
2025
Q4 		$8.91M Buy
409,974
+194,747
+90% +$5.58M 0.01% 1136
2025
Q3 		$7.02M Buy
215,227
+66,546
+45% +$2.46M 0.01% 1265
2025
Q2 		$5.28M Buy
148,681
+64,956
+78% +$2.1M 0.01% 1425
2025
Q1 		$2.84M Sell
83,725
-44,175
-35% -$1.58M ﹤0.01% 1827
2024
Q4 		$4.16M Buy
127,900
+39,197
+44% +$1.62M ﹤0.01% 1794
2024
Q3 		$4.32M Buy
88,703
+19,303
+28% +$1.03M 0.01% 1506
2024
Q2 		$3.07M Sell
69,400
-32,334
-32% -$1.49M 0.01% 1725
2024
Q1 		$5.71M Buy
101,734
+443
+0.4% +$26.7K 0.01% 1358
2023
Q4 		$6.09M Buy
101,291
+68,427
+208% +$4.34M 0.01% 1274
2023
Q3 		$2.21M Sell
32,864
-33,412
-50% -$2.32M 0.01% 1733
2023
Q2 		$4.58M Buy
66,276
+44,991
+211% +$2.94M 0.01% 1127
2023
Q1 		$1.03M Buy
21,285
+2,097
+11% +$103K ﹤0.01% 1879
2022
Q4 		$958K Sell
19,188
-26,494
-58% -$1.28M ﹤0.01% 1851
2022
Q3 		$1.86M Buy
45,682
+21,806
+91% +$1.02M 0.01% 1360
2022
Q2 		$1.31M Sell
23,876
-5,598
-19% -$236K 0.01% 1437
2022
Q1 		$1.07M Buy
29,474
+11,998
+69% +$474K ﹤0.01% 1550
2021
Q4 		$815K Buy
+17,476
New +$887K ﹤0.01% 1826

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Squarepoint's LEGN Position: Q2 2026 in Review

Squarepoint increased its Legend Biotech (LEGN) stake by 60% in Q2 2026, buying an estimated $7.82M and bringing the position to 769,252 shares worth $22.2M. The position accounts for 0.02% of the portfolio, ranked #654.

Squarepoint first reported a position in LEGN in Q4 2021 and has held it in 19 quarters since. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Squarepoint held 769,252 shares of Legend Biotech worth $22.2M as of Q2 2026.
  • Squarepoint bought 289,772 Legend Biotech shares in Q2 2026, an estimated $7.82M.
  • Legend Biotech made up 0.02% of Squarepoint's portfolio in Q2 2026, its #654 holding.
  • Squarepoint first reported a position in Legend Biotech in Q4 2021 and has held it in 19 quarters since.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.